Publications 2008 - 2010

2008

Reid, A., Naresh, K., Wagner, S., & Macdonald, D. (2008). Interphase FISH using a BCL3 probe to diagnose the t(14;19)(q32;q13)-positive small B-cell leukemia. Leukaemia and Lymphoma (Current Medical Literature), 49, 356-358.

2009

Batlle, A., Papadopoulou, V., Gomes, A. R., Willimott, S., Melo, J., Naresh, K.,  Wagner, S. D. (2009). CD40 and B-cell receptor signalling induce MAPK family members that can either induce or repress Bcl-6 expression. Molecular Immunology, 46, 1727-1735. doi:10.1016/j.molimm.2009.02.003  

Sheth, A., de Melo, V. A., Szydlo, R., MacDonald, D. H., Reid, A. G., & Wagner, S. D. (2009). Specific patterns of chromosonal gains and losses associate with t(3;14), t(8;14), and t (14;18) in diffuse large B-cell lymphoma.. Cancer Genetics and Cytogenetics, 194(1), 48-52.

Ambrose, H. E., Willimott, S., Beswick, R. W., Dantzer, F., de Murcia, J., Yelamos, J., Wagner, S. D. (2009). Poly(ADP-ribose) polymerase-1 (Parp-1) deficient mice demonstrate abnormal antibody responses. Immunology, 127(2), 178-186.

Khorashad, J. S., Wagner, S., Greener, L., Marin, D., Reid, A. G., Milojkovic, D.,  Foroni, L. (2009). The level of BCR-ABL1 kinase activity before treatment does not identify CML patients who fail to achieve a complete cytogenetic response on Imatinib. Haematologica, 94, 861-864.

2010 

Hoffman, T., Stadler, L. K., Busby, M., Song, Q., Buxton, A. T., Wagner, S. D., Ko Ferrigno, P. (2010). Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SWM variant.. Protein Engineering Design and Selection, Epub ahead of print(PMID 20179045).

Majid, A., Lin, T. T., Best, G., Fishlock, K., Hewamana, S., Pratt, G., Pepper, C. (2010). CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.. Leukemia Research, Epub ahead of print.

Willimott, S., & Wagner, S. D. (2010). Post-transcriptional and post-translational regulation of Bcl2.. Biochem Soc Trans, 38(6), 1571-1575. doi:10.1042/BST0381571

Hoffmann, T., Stadler, L. K. J., Busby, M., Song, Q., Buxton, A. T., Wagner, S. D., Ferrigno, P. K. (2010). Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant. PROTEIN ENGINEERING DESIGN & SELECTION, 23(5), 403-413. doi:10.1093/protein/gzq012

Papadopoulou, V., Postigo, A., Sanchez-Tillo, E., Porter, A. C. G., & Wagner, S. D. (2010). ZEB1 and CtBP form a repressive complex at a distal promoter element of the BCL6 locus. BIOCHEM J, 427(3), 541-550. doi:10.1042/BJ20091578

 

 

Share this page:

NEWS

Powerful pre-clinical platform for anti-cancer drug and biomarker discovery

Pre-clinical models that can accurately predict outcomes in the clinic are much sort after in the field of cancer drug discovery and development.  Read about how patient derived explants offer many advantages and are the powerful model of choice. A copy of the review, published in the British Journal of Cancer, is available by clicking this link: PDE Platform

---------------------------------

SEND Study Success

Congratulations to Chris Avery, who with collaborating colleagues published findings of the SEND study, a multi-centre randomised trial using two different surgical protocols for mouth cancer treatment.  A nationwide first for this type of trial, using real-world data.  The paper, published in the British Journal of Cancer, is available by clicking this link: SEND Paper

---------------------------------

Centre Health and Wellbeing Group
Join up for a walk on the park Friday lunchtime - details here.

More information from Jenny McNair jm65@le.ac.uk

Contact Details

Leicester Cancer Research Centre
Robert Kilpatrick Clinical Sciences Building
University of Leicester
Leicester Royal Infirmary
Leicester LE2 7LX

T: +44 (0) 116 252 3170
E: cancerstudies@le.ac.uk

(Please note this email address should not be used for clinical referrals or patient correspondence)

Maps and Directions

Sat Nav users: 
LE1 5WW

Accessibility

AccessAble logo

The University of Leicester is committed to equal access to our facilities. DisabledGo has a detailed accessibility guide for the Robert Kilpatrick Clinical Sciences Building.

Seminars

.